Article
Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
Internal medicine journal - 1 Oct 2005
Gearry R B, Barclay M L, Roberts R L, Harraway J, Zhang M, Pike L S, George P M, Florkowski C M
Abstract excerpt
BACKGROUND: Azathioprine and 6-mercaptopurine (6-MP) are well established for the treatment of inflammatory bowel disease (IBD). Assessing thiopurine methyltransferase (TPMT) status has been recommended to reduce the risk of serious toxicity. Measuring red blood cell (RBC) 6-thioguanine nucleotid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
